Dario A. Paggiarino's Net Worth

$3.03 Million

Estimate Recalculated Sep 8, 2024 07:20PM EST

Who is Dario A. Paggiarino?

Dario A. Paggiarino has an estimated net worth of $3.03 Million. This is based on reported shares across multiple companies, which include EyePoint Pharmaceuticals, Inc., and LPATH, INC.

SEC CIK

Dario A. Paggiarino's CIK is 0001574261

Past Insider Trading and Trends

2024 was Dario A. Paggiarino's most active year for acquiring shares with 18 total transactions. Dario A. Paggiarino's most active month to acquire stocks was the month of May. 2024 was Dario A. Paggiarino's most active year for disposing of shares, totalling 32 transactions. Dario A. Paggiarino's most active month to dispose stocks was the month of December. 2024 saw Dario A. Paggiarino paying a total of $939,932.04 for 228,713 shares, this is the most they've acquired in one year. In 2024 Dario A. Paggiarino cashed out on 290,053 shares for a total of $2,940,414.42, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

EyePoint Pharmaceuticals, Inc. (EYPT) Snapshot price: $7.97

Chief Medical Officer

Dario A. Paggiarino owns 67,080 units of Common stock which is worth $534,627.60. In the year 2024 Dario A. Paggiarino filed a total of 33 filings.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+58.87%
24.86K
$20.67
-$528,035.82
67.08K
Mar 30
Form 4
+15.66%
5.72K
$28.80
-$146,390.40
42.22K
Feb 9
Form 4
—
0
$19.36
-$621,491.79
36.51K
Jan 26
Form 4
—
0
$19.01
-$7,191.00
36.51K
Jan 25
Form 4
—
0
$19.02
-$196,410.76
36.51K
Jan 23 - Jan 24
Form 4
—
0
$12.20
-$409,427.81
36.51K
Jan 8
Form 4
+42.00%
10.8K
$20.40
-$91,534.80
36.51K
Jan 5 - Jan 6
Form 4
—
0
$15.07
-$14,390.46
25.71K
Dec 13
Form 4
—
0
$16.07
-$363,518.75
25.71K
Dec 4
Form 4
—
0
—
—
0
Jun 20
Form 4
+37.83%
7.06K
$4.17
-$15,612.48
25.71K
Feb 9
Form 4
—
0
—
—
0
Jan 6
Form 4
+17.75%
2.81K
$9.95
-$12,875.30
18.65K
Feb 28
Form 4
+25.76%
3.25K
$10.13
-$17,433.73
15.84K
Feb 9
Form 4
—
0
—
—
0
Jun 22
Form 4
+8.65%
1K
$9.72
-$4,053.24
12.6K
Jun 14
Form 4
+30.10%
2.68K
$10.81
-$15,382.63
11.59K
Feb 28
Form 4
+48.22%
29K
$0.76
-$9,121.09
89.14K
Jun 30
Form 4
+13.31%
7.06K
$0.79
-$2,316.50
60.14K
Jun 27
Form 4
+23.30%
10.03K
$0.83
-$3,441.10
53.08K
Jun 14
Form 4
—
0
—
—
0
Feb 28
Form 4
-5.38%
-2.45K
$2.11
-$5,157.25
43.05K
Oct 12
Form 4
+18.37%
7.06K
$1.65
-$4,851.00
45.5K
Jun 27
Form 4
—
0
—
—
0
Jun 25
Form 4
+35.28%
10.03K
$1.53
-$6,387.75
38.44K
Jun 14
Form 4
-4.01%
-1.19K
$2.47
-$2,934.36
28.41K
Mar 19
Form 4
+92.36%
14.21K
$3.23
-$7,929.65
29.6K
Oct 12
Form 4
+84.66%
7.05K
$1.86
-$5,477.70
15.39K
Jun 27
Form 4
—
0
—
—
0
Jun 14
Form 4
∞
8.33K
—
—
8.33K
Mar 19
Form 4
—
0
—
—
0
Jun 27
Form 4
—
0
—
—
0
Aug 1
Form 3
—
0
—
—
0
No matching records found

LPATH, INC No price found

Chief Development Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Feb 16
Form 4
—
0
—
—
0
Jun 16
Form 4
—
0
—
—
0
Feb 9
Form 4
—
0
—
—
0
Feb 10
Form 4
—
0
—
—
0
Jun 19
Form 3
—
0
—
—
0
No matching records found